120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
急性基孔肯雅热的临床特征及疾病严重程度相关因素：一项回顾性分析
Authors Lin H , Xie S , Li K, Chen Z, Wang Y
Received 15 October 2025
Accepted for publication 6 February 2026
Published 12 February 2026 Volume 2026:19 569624
DOI https://doi.org/10.2147/IDR.S569624
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Oliver Planz
Hanjie Lin,1,* Shan Xie,1,* Kai Li,1 Zhanqin Chen,2 Yue Wang1
1Department of Clinical Laboratory, Foshan Women and Children Hospital Affiliated to Guangdong Medical University, Foshan, Guangdong, 528000, People’s Republic of China; 2Department of Information, Foshan Women and Children Hospital Affiliated to Guangdong Medical University, Foshan, Guangdong, 528000, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Yue Wang, Email 912147216@qq.com
Background: Chikungunya fever has emerged as a significant public health concern in tropical and subtropical regions worldwide. Understanding the epidemiological patterns and clinical features of chikungunya virus infection is crucial for developing effective disease surveillance and management strategies.
Methods: We conducted a retrospective analysis of 311 laboratory-confirmed chikungunya fever cases presenting to a tertiary hospital in Foshan, Guangdong Province, China, from June to September 2025.
Results: The study population had a median age of 32.35 years (interquartile range: 10– 53 years), with females comprising 56.3%. Fever occurred in 85.9% of patients, with 49.2% experiencing moderate to high-grade fever. Joint symptoms were present in 76.5% of patients, with 48.6% developing moderate to severe arthralgia. Rash was a significant clinical manifestation with an incidence of 73%, of which 44.1% of patients presented with severe rash. Laboratory abnormalities included leukopenia (6.4%), lymphopenia (64.6%), and elevated C-reactive protein (66.2%). Multivariate analysis identified rash presence, joint symptoms, and younger age as factors significantly associated with moderate-severe disease presentations. However, as rash and joint symptom severity were incorporated into the severity scoring system, these associations should be interpreted as descriptive characterization rather than independent prediction.
Conclusion: This study characterizes the clinical features of acute chikungunya fever, with age-related severity differences and specific clinical and laboratory markers associated with disease severity. Rash emerges as a significant clinical manifestation associated with disease severity, highlighting its value in clinical assessment of chikungunya fever. These findings support the development of risk stratification tools and evidence-based management protocols for chikungunya fever patients.
Keywords: chikungunya fever, epidemiology, clinical features, disease severity, arboviral infection, rash
1Department of Clinical Laboratory, Foshan Women and Children Hospital Affiliated to Guangdong Medical University, Foshan, Guangdong, 528000, People’s Republic of China; 2Department of Information, Foshan Women and Children Hospital Affiliated to Guangdong Medical University, Foshan, Guangdong, 528000, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Yue Wang, Email 912147216@qq.com
Background: Chikungunya fever has emerged as a significant public health concern in tropical and subtropical regions worldwide. Understanding the epidemiological patterns and clinical features of chikungunya virus infection is crucial for developing effective disease surveillance and management strategies.
Methods: We conducted a retrospective analysis of 311 laboratory-confirmed chikungunya fever cases presenting to a tertiary hospital in Foshan, Guangdong Province, China, from June to September 2025.
Results: The study population had a median age of 32.35 years (interquartile range: 10– 53 years), with females comprising 56.3%. Fever occurred in 85.9% of patients, with 49.2% experiencing moderate to high-grade fever. Joint symptoms were present in 76.5% of patients, with 48.6% developing moderate to severe arthralgia. Rash was a significant clinical manifestation with an incidence of 73%, of which 44.1% of patients presented with severe rash. Laboratory abnormalities included leukopenia (6.4%), lymphopenia (64.6%), and elevated C-reactive protein (66.2%). Multivariate analysis identified rash presence, joint symptoms, and younger age as factors significantly associated with moderate-severe disease presentations. However, as rash and joint symptom severity were incorporated into the severity scoring system, these associations should be interpreted as descriptive characterization rather than independent prediction.
Conclusion: This study characterizes the clinical features of acute chikungunya fever, with age-related severity differences and specific clinical and laboratory markers associated with disease severity. Rash emerges as a significant clinical manifestation associated with disease severity, highlighting its value in clinical assessment of chikungunya fever. These findings support the development of risk stratification tools and evidence-based management protocols for chikungunya fever patients.
Keywords: chikungunya fever, epidemiology, clinical features, disease severity, arboviral infection, rash